Legis Daily

To ensure that an individual who is transitioning from receiving medical treatment furnished by the Secretary of Defense to medical treatment furnished by the Secretary of Veterans Affairs receives the pharmaceutical agents required for such transition.

USA115th CongressHR-1063| House 
| Updated: 9/26/2017
Beto O'Rourke

Beto O'Rourke

Democratic Representative

Texas

Cosponsors (6)
Kathleen M. Rice (Democratic)Dina Titus (Democratic)Scott H. Peters (Democratic)Walter B. Jones (Republican)Bob Goodlatte (Republican)Mike Coffman (Republican)

Health Subcommittee, Veterans' Affairs Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Veteran Prescription Continuity Act This bill amends the National Defense Authorization Act for Fiscal Year 2016 to direct the Department of Veterans Affairs (VA) to furnish an individual who is transitioning from Department of Defense (DOD)- to VA-furnished medical treatment any pharmaceutical agent not included in the joint uniform formulary if a DOD health care provider determines that the pharmaceutical agent is critical for the transition. The VA shall furnish an individual with such pharmaceutical agent: (1) beginning when the individual enrolls in the VA health care system, and (2) ending when a DOD health care provider determines that the individual does not require the pharmaceutical agent.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 15, 2017
Introduced in House
Feb 15, 2017
Referred to the House Committee on Veterans' Affairs.
Mar 3, 2017
Referred to the Subcommittee on Health.
Sep 26, 2017
Subcommittee Hearings Held.
  • February 15, 2017
    Introduced in House


  • February 15, 2017
    Referred to the House Committee on Veterans' Affairs.


  • March 3, 2017
    Referred to the Subcommittee on Health.


  • September 26, 2017
    Subcommittee Hearings Held.

Armed Forces and National Security

Military medicinePrescription drugsVeterans' medical care

To ensure that an individual who is transitioning from receiving medical treatment furnished by the Secretary of Defense to medical treatment furnished by the Secretary of Veterans Affairs receives the pharmaceutical agents required for such transition.

USA115th CongressHR-1063| House 
| Updated: 9/26/2017
Veteran Prescription Continuity Act This bill amends the National Defense Authorization Act for Fiscal Year 2016 to direct the Department of Veterans Affairs (VA) to furnish an individual who is transitioning from Department of Defense (DOD)- to VA-furnished medical treatment any pharmaceutical agent not included in the joint uniform formulary if a DOD health care provider determines that the pharmaceutical agent is critical for the transition. The VA shall furnish an individual with such pharmaceutical agent: (1) beginning when the individual enrolls in the VA health care system, and (2) ending when a DOD health care provider determines that the individual does not require the pharmaceutical agent.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 15, 2017
Introduced in House
Feb 15, 2017
Referred to the House Committee on Veterans' Affairs.
Mar 3, 2017
Referred to the Subcommittee on Health.
Sep 26, 2017
Subcommittee Hearings Held.
  • February 15, 2017
    Introduced in House


  • February 15, 2017
    Referred to the House Committee on Veterans' Affairs.


  • March 3, 2017
    Referred to the Subcommittee on Health.


  • September 26, 2017
    Subcommittee Hearings Held.
Beto O'Rourke

Beto O'Rourke

Democratic Representative

Texas

Cosponsors (6)
Kathleen M. Rice (Democratic)Dina Titus (Democratic)Scott H. Peters (Democratic)Walter B. Jones (Republican)Bob Goodlatte (Republican)Mike Coffman (Republican)

Health Subcommittee, Veterans' Affairs Committee

Armed Forces and National Security

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Military medicinePrescription drugsVeterans' medical care